-
1
-
-
85030726543
-
-
Disponible en: www.ine.es/encuesta de morbilidad hospitalaria
-
Disponible en: www.ine.es/encuesta de morbilidad hospitalaria 2001.
-
(2001)
-
-
-
2
-
-
0012376212
-
Hypertension with left ventricular hypertrophy/diastolic dysfunction
-
Sleight P, Bakris G, Mancia G, Messerli F, Opie L, editors. Richmond upon Thames (Reino Unido): PAN Communications
-
Barrios V, Ruilope LM. Hypertension with left ventricular hypertrophy/diastolic dysfunction. En: Sleight P, Bakris G, Mancia G, Messerli F, Opie L, editors. Clinical cases in hypertension. Specific treatment strategies (volume two). Richmond upon Thames (Reino Unido): PAN Communications, 2000. p. 16-22.
-
(2000)
Clinical Cases in Hypertension. Specific Treatment Strategies
, vol.2
, pp. 16-22
-
-
Barrios, V.1
Ruilope, L.M.2
-
3
-
-
0035089266
-
Prognostic implications of left ventricular hypertrophy
-
Vakili BA, Okin PM, Devereux RB. Prognostic implications of left ventricular hypertrophy. Am Heart J. 2001;141:334-41.
-
(2001)
Am. Heart J.
, vol.141
, pp. 334-341
-
-
Vakili, B.A.1
Okin, P.M.2
Devereux, R.B.3
-
4
-
-
0035940391
-
Left ventricular hypertrophy as an independient predictor of acute cerebrovascular events in essential hypertension
-
Verdecchia P, Porcellatti C, Reboldi G, Gattobigio R, Borgioni C, Pearson TA, et al. Left ventricular hypertrophy as an independient predictor of acute cerebrovascular events in essential hypertension. Circulation. 2001; 104:2039-44.
-
(2001)
Circulation
, vol.104
, pp. 2039-2044
-
-
Verdecchia, P.1
Porcellatti, C.2
Reboldi, G.3
Gattobigio, R.4
Borgioni, C.5
Pearson, T.A.6
-
5
-
-
0033991103
-
The influence of antihypertensive drug treatment on the prevention and regression of left ventricular hypertrophy
-
Van Zwieten PA. The influence of antihypertensive drug treatment on the prevention and regression of left ventricular hypertrophy. Cardiovasc Res. 2000;45:82-91.
-
(2000)
Cardiovasc. Res.
, vol.45
, pp. 82-91
-
-
Van Zwieten, P.A.1
-
7
-
-
0043164975
-
Regression of electrocardiographic left ventricular hypertrophy by losartan versus atenolol. The Losartan Intervention For Endpoint reduction in hypertension: LIFE study
-
Okin PM, Devereaux RB, Jem S, Kjeldsen SE, Julius S, Nieminen MS, et al. Regression of electrocardiographic left ventricular hypertrophy by losartan versus atenolol. The Losartan Intervention For Endpoint reduction in hypertension: LIFE study. Circulation. 2003;108:684-90.
-
(2003)
Circulation
, vol.108
, pp. 684-690
-
-
Okin, P.M.1
Devereaux, R.B.2
Jem, S.3
Kjeldsen, S.E.4
Julius, S.5
Nieminen, M.S.6
-
8
-
-
0035797832
-
Reduction of cardiovascular risk by regression of electrocardiographic markers of left ventricular hypertrophy by the angiotensin-converting enzyme inhibitor ramipril
-
Mathew J, Sleight P, Lonn E, Johnstone D, Pogue J, Yi Q et al. Reduction of cardiovascular risk by regression of electrocardiographic markers of left ventricular hypertrophy by the angiotensin-converting enzyme inhibitor ramipril. Circulation. 2001;104:1615-21.
-
(2001)
Circulation
, vol.104
, pp. 1615-1621
-
-
Mathew, J.1
Sleight, P.2
Lonn, E.3
Johnstone, D.4
Pogue, J.5
Yi, Q.6
-
9
-
-
0037160968
-
Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): A randomised trial against atenolol
-
Dahlof B, Devereaux R, Kjeldesen S, Julius S, Beevers G, de Faire U, et al. Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol. Lancet. 2002;359:995-1003.
-
(2002)
Lancet
, vol.359
, pp. 995-1003
-
-
Dahlof, B.1
Devereaux, R.2
Kjeldesen, S.3
Julius, S.4
Beevers, G.5
de Faire, U.6
-
10
-
-
0038642326
-
A meta-analysis of the effects of treatment on left ventricular mass in essential hypertension
-
Klingbeil AV, Schneider M, Martus P, Messerli FH, Schmieder RE. A meta-analysis of the effects of treatment on left ventricular mass in essential hypertension. Am J Med. 2003;115:41-6.
-
(2003)
Am. J. Med.
, vol.115
, pp. 41-46
-
-
Klingbeil, A.V.1
Schneider, M.2
Martus, P.3
Messerli, F.H.4
Schmieder, R.E.5
-
11
-
-
0028035369
-
Prognostic implications of baseline electrocardiographic features and their serial changes in subjects with left ventricular hypertrophy
-
Levy D, Salomon M, D'Agostino RB, Belanger AJ, Kannel WB. Prognostic implications of baseline electrocardiographic features and their serial changes in subjects with left ventricular hypertrophy. Circulation. 1994; 90:1786-93.
-
(1994)
Circulation
, vol.90
, pp. 1786-1793
-
-
Levy, D.1
Salomon, M.2
D'Agostino, R.B.3
Belanger, A.J.4
Kannel, W.B.5
-
12
-
-
0031963796
-
Prognostic significance of serial changes in left ventricular mass in essential hypertension
-
Verdecchia P, Schillacci G, Borgioni C, Ciucci A, Gattobigio R, Zampi I, et al. Prognostic significance of serial changes in left ventricular mass in essential hypertension. Circulation. 1998;97:48-54.
-
(1998)
Circulation
, vol.97
, pp. 48-54
-
-
Verdecchia, P.1
Schillacci, G.2
Borgioni, C.3
Ciucci, A.4
Gattobigio, R.5
Zampi, I.6
-
13
-
-
0142200439
-
Changes in cardiovascular risk by reduction of left ventricular mass in hipertension: A meta-analysis
-
Verdecchia P, Angeli F, Borgioni C, Gattobigio R, de Simeone G, Devereux RB, et al. Changes in cardiovascular risk by reduction of left ventricular mass in hipertension: a meta-analysis. Am J Hypertens. 2003;16:895-9.
-
(2003)
Am. J. Hypertens.
, vol.16
, pp. 895-899
-
-
Verdecchia, P.1
Angeli, F.2
Borgioni, C.3
Gattobigio, R.4
de Simeone, G.5
Devereux, R.B.6
-
14
-
-
85030730903
-
-
Disponible: en www.ine.es/encuesta de morbilidad hospitalaria
-
Disponible: en www.ine.es/encuesta de morbilidad hospitalaria 2001.
-
(2001)
-
-
-
15
-
-
27744437348
-
Tratamiento de la cardiopatía hipertensiva
-
Barrios V, editor. Madrid: Momento Médico Iberoamericana
-
Barrios V. Tratamiento de la cardiopatía hipertensiva. En: Barrios V, editor. Hipertensión y corazón. Madrid: Momento Médico Iberoamericana; 2003. p. 53-64.
-
(2003)
Hipertensión Y Corazón
, pp. 53-64
-
-
Barrios, V.1
-
16
-
-
0343487983
-
Randomised double-blind comparision of placebo an active treatment for older patients with isolated systolic hypertension
-
Staessen JA, Fagard R, Thijs JL, Celis H, Arabidze GG, Birkenhader WH, et al. Randomised double-blind comparision of placebo an active treatment for older patients with isolated systolic hypertension. Lancet. 1997;350: 757-64.
-
(1997)
Lancet
, vol.350
, pp. 757-764
-
-
Staessen, J.A.1
Fagard, R.2
Thijs, J.L.3
Celis, H.4
Arabidze, G.G.5
Birkenhader, W.H.6
-
17
-
-
27744531954
-
Insuficiencia cardíaca en hipertensión arterial
-
Barrios V, Lozano F. Insuficiencia cardíaca en hipertensión arterial. Enf Vasc Hipertens. 1997;8:5-16.
-
(1997)
Enf. Vasc. Hipertens.
, vol.8
, pp. 5-16
-
-
Barrios, V.1
Lozano, F.2
-
18
-
-
0027941077
-
Left ventricular diastolic dysfunction in hypertension
-
Fouad-Tarazi FM. Left ventricular diastolic dysfunction in hypertension. Curr Opin Cardiol. 1994;551-60.
-
(1994)
Curr. Opin. Cardiol.
, pp. 551-560
-
-
Fouad-Tarazi, F.M.1
-
19
-
-
0041408234
-
Effects of candesartan in patients with chronic heart failure and preserved left-ventricular ejection fraction: The CHARM-Preserved Trial
-
for the CHARM Investigators and Committees
-
Yusuf S, Pfeffer MA, Swedberg K, Granger CB, Held P, McMurray JJV, et al for the CHARM Investigators and Committees. Effects of candesartan in patients with chronic heart failure and preserved left-ventricular ejection fraction: the CHARM-Preserved Trial. Lancet. 2003;362: 777-81.
-
(2003)
Lancet
, vol.362
, pp. 777-781
-
-
Yusuf, S.1
Pfeffer, M.A.2
Swedberg, K.3
Granger, C.B.4
Held, P.5
McMurray, J.J.V.6
-
20
-
-
0029960897
-
Prevention of disease progression, left ventricular hypertrophy and congestive heart failure in hypertension treatment trials
-
Moser M, Hebert PR. Prevention of disease progression, left ventricular hypertrophy and congestive heart failure in hypertension treatment trials. J Am Coll Cardiol. 1996;27:1214-8.
-
(1996)
J. Am. Coll. Cardiol.
, vol.27
, pp. 1214-1218
-
-
Moser, M.1
Hebert, P.R.2
-
21
-
-
0033034404
-
Effect of angiotensin converting enzyme inhibition compared with conventional therapy on cardiovascular morbidity and mortality in hypertension. The CAPPP randomised trial
-
Hansson L, Lindholm JH, Niskanen L, Lanke J, Hedner T, Niklason A, et al. Effect of angiotensin converting enzyme inhibition compared with conventional therapy on cardiovascular morbidity and mortality in hypertension. The CAPPP randomised trial. Lancet. 1999;353:611-6.
-
(1999)
Lancet
, vol.353
, pp. 611-616
-
-
Hansson, L.1
Lindholm, J.H.2
Niskanen, L.3
Lanke, J.4
Hedner, T.5
Niklason, A.6
-
22
-
-
0034688194
-
Effects of an angiotensin-converting-enzyme inhibitor, ramipril on cardiovascular events in high risk patients. The Heart Outcomes Prevention Evaluation (HOPE) Study
-
The Heart Outcomes Prevention Evaluation Study Investigators
-
The Heart Outcomes Prevention Evaluation Study Investigators. Effects of an angiotensin-converting-enzyme inhibitor, ramipril on cardiovascular events in high risk patients. The Heart Outcomes Prevention Evaluation (HOPE) Study. N Engl J Med. 2000;342:145-53.
-
(2000)
N. Engl. J. Med.
, vol.342
, pp. 145-153
-
-
-
23
-
-
0346962877
-
Meta-analysis of effectiveness or lack thereof of angiotensin-converting enzyme inhibitors for prevention of heart faliure in patients with systemic hipertension
-
Angeli F, Verdecchia P, Reboldi GP, Gattobigio R, Bentivoglio M, Staessen JA, et al. Meta-analysis of effectiveness or lack thereof of angiotensin-converting enzyme inhibitors for prevention of heart faliure in patients with systemic hipertension. J Am Coll Cardiol. 2004;93:240-3.
-
(2004)
J. Am. Coll. Cardiol.
, vol.93
, pp. 240-243
-
-
Angeli, F.1
Verdecchia, P.2
Reboldi, G.P.3
Gattobigio, R.4
Bentivoglio, M.5
Staessen, J.A.6
-
24
-
-
0025942936
-
Morbidity and mortality in the Swedish trial in older patients with hypertension
-
Dahlöf B, Lindholm LH, Hansson L, Schersten B, Ekbom T, Wester PO, et al. Morbidity and mortality in the Swedish trial in older patients with hypertension. Lancet. 1991;338:1281-5.
-
(1991)
Lancet
, vol.338
, pp. 1281-1285
-
-
Dahlöf, B.1
Lindholm, L.H.2
Hansson, L.3
Schersten, B.4
Ekbom, T.5
Wester, P.O.6
-
25
-
-
0000220739
-
Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension
-
SHEP Cooperative Research Group
-
SHEP Cooperative Research Group. Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension. JAMA. 1991;266:3255-64.
-
(1991)
JAMA
, vol.266
, pp. 3255-3264
-
-
-
26
-
-
0029886630
-
Blood pressure as a cardiovascular risk factor
-
Kannel WB. Blood pressure as a cardiovascular risk factor. JAMA. 1996;275:1571-6.
-
(1996)
JAMA
, vol.275
, pp. 1571-1576
-
-
Kannel, W.B.1
-
27
-
-
85030732600
-
Outcomes in hypertensive patients at high cardiovascular risk treated with regimens base don valsartan or amlodipine: The VALUE randomised trial
-
Published online June 14, Disponible en:
-
Julius S, Kjeldsen SE, Weber M, Brunner HR, Ekman S, Hansson L, et al. Outcomes in hypertensive patients at high cardiovascular risk treated with regimens base don valsartan or amlodipine: the VALUE randomised trial. Published online June 14, 2004. Disponible en: http://image.thelancet.com/extras/04art4187web.pdf
-
(2004)
-
-
Julius, S.1
Kjeldsen, S.E.2
Weber, M.3
Brunner, H.R.4
Ekman, S.5
Hansson, L.6
-
28
-
-
1942520942
-
Stroke prevention, blood cholesterol and statins
-
Amarenco P, Lavallee P, Touboul PJ. Stroke prevention, blood cholesterol and statins. Lancet Neurol. 2004;3(5):271-8.
-
(2004)
Lancet Neurol.
, vol.3
, Issue.5
, pp. 271-278
-
-
Amarenco, P.1
Lavallee, P.2
Touboul, P.J.3
-
29
-
-
2642626655
-
Economic consequences of diabetes mellitus in the US in 1997
-
American Diabetes Association
-
American Diabetes Association. Economic consequences of diabetes mellitus in the US in 1997. Diabetes Care. 1998;21:269-309.
-
(1998)
Diabetes Care
, vol.21
, pp. 269-309
-
-
-
30
-
-
0032511580
-
Tight blood pressure control and risk of cardiovascular and microvascular complications in type 2 diabetes: UKPDS 38
-
UK Prospective Diabetes Study (UKPDS) Group
-
UK Prospective Diabetes Study (UKPDS) Group Tight blood pressure control and risk of cardiovascular and microvascular complications in type 2 diabetes: UKPDS 38. BMJ. 1998;317:703-13.
-
(1998)
BMJ
, vol.317
, pp. 703-713
-
-
-
31
-
-
0028299731
-
Independent risk factors for atrial fibrillation in a population-based cohort. The Framingham Heart Study
-
Benjamín EJ, Levy D, Vais SM, D'Agostino RB, Belanger AJ, Wolf PA. Independent risk factors for atrial fibrillation in a population-based cohort. The Framingham Heart Study. JAMA. 1994;271:840-4.
-
(1994)
JAMA
, vol.271
, pp. 840-844
-
-
Benjamín, E.J.1
Levy, D.2
Vais, S.M.3
D'Agostino, R.B.4
Belanger, A.J.5
Wolf, P.A.6
-
32
-
-
0020074665
-
Epidemiological features of chronic atrial fibrillation: The Framingham Study
-
Kannel WB, Abbott RD, Savage DD, McNamara PM. Epidemiological features of chronic atrial fibrillation: the Framingham Study. N Engl J Med. 1982;306:1018-22.
-
(1982)
N. Engl. J. Med.
, vol.306
, pp. 1018-1022
-
-
Kannel, W.B.1
Abbott, R.D.2
Savage, D.D.3
McNamara, P.M.4
-
33
-
-
0027437748
-
Asymptomatic ventricular arrhythmias and mortality risk in subjects with left ventricular hypertrophy
-
Bikkina M, Larson MG, Benjamin EJ, Levy D. Asymptomatic ventricular arrhythmias and mortality risk in subjects with left ventricular hypertrophy. J Am Coll Cardiol. 1993;22:1111-6.
-
(1993)
J. Am. Coll. Cardiol.
, vol.22
, pp. 1111-1116
-
-
Bikkina, M.1
Larson, M.G.2
Benjamin, E.J.3
Levy, D.4
-
34
-
-
0028800258
-
Evidence favoring the hipothesis that ventricular arrhythmias have prognosis significance in left ventricular hypertrophy secondary to systemic hipertensión
-
Almendral J, Villacastín JP, Arenal A, Tercedor L, Merino JL, Delcán JL. Evidence favoring the hipothesis that ventricular arrhythmias have prognosis significance in left ventricular hypertrophy secondary to systemic hipertensión. Am J Cardiol 1995;76 Suppl D:D60-3.
-
(1995)
Am. J. Cardiol.
, vol.76
, Issue.SUPPL. D
-
-
Almendral, J.1
Villacastín, J.P.2
Arenal, A.3
Tercedor, L.4
Merino, J.L.5
Delcán, J.L.6
|